BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 24632282)

  • 1. Current treatment of in-stent restenosis.
    Alfonso F; Byrne RA; Rivero F; Kastrati A
    J Am Coll Cardiol; 2014 Jun; 63(24):2659-73. PubMed ID: 24632282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
    Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
    Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
    J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restenosis in bare metal and drug-eluting stents: distinct mechanistic insights from histopathology and optical intravascular imaging.
    Byrne RA; Joner M; Tada T; Kastrati A
    Minerva Cardioangiol; 2012 Oct; 60(5):473-89. PubMed ID: 23018428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restenosis of Drug-Eluting Stents: A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review.
    Shlofmitz E; Iantorno M; Waksman R
    Circ Cardiovasc Interv; 2019 Aug; 12(8):e007023. PubMed ID: 31345066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of coronary artery in-stent restenosis.
    Kokkinidis DG; Waldo SW; Armstrong EJ
    Expert Rev Cardiovasc Ther; 2017 Mar; 15(3):191-202. PubMed ID: 28116914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus- and zotarolimus-eluting stents for bare metal stent in-stent restenosis treatment: a prospective study.
    Toutouzas K; Patsa C; Tsiamis E; Tsioufis C; Spanos A; Stefanadi E; Tentolouris C; Stefanadis C
    J Interv Cardiol; 2008 Oct; 21(5):388-94. PubMed ID: 18705639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis.
    Singh IM; Filby SJ; Sakr FE; Gorodeski EZ; Lincoff AM; Ellis SG; Shishehbor MH
    Catheter Cardiovasc Interv; 2010 Feb; 75(3):338-42. PubMed ID: 19937786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory In-Stent Restenosis: Improving Outcomes by Standardizing Our Approach.
    Waksman R; Iantorno M
    Curr Cardiol Rep; 2018 Oct; 20(12):140. PubMed ID: 30350271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome after management of unprotected left main in-stent restenosis after bare metal or drug-eluting stents.
    Chen SL; Xu B; Mintz G; Ye F; Zhang JJ; Kan J; Sun XW; Zhang AP; Chen JG; Qian J; Kwan TW
    Chin Med J (Engl); 2010 Apr; 123(7):794-9. PubMed ID: 20497666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kissing drug-eluting balloons for the treatment of unprotected distal left main bifurcation drug-eluting stent restenosis.
    Ielasi A; Anzuini A
    Cardiovasc Revasc Med; 2012; 13(6):347-9. PubMed ID: 23000439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study.
    Habara M; Terashima M; Nasu K; Kaneda H; Yokota D; Ito T; Kurita T; Teramoto T; Kimura M; Kinoshita Y; Tsuchikane E; Asakura Y; Suzuki T
    Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):276-84. PubMed ID: 22945378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis.
    Torguson R; Sabate M; Deible R; Smith K; Chu WW; Kent KM; Pichard AD; Suddath WO; Satler LF; Waksman R
    Am J Cardiol; 2006 Nov; 98(10):1340-4. PubMed ID: 17134625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options for stent restenosis: insights from intracoronary imaging, clinical trials, and registries.
    Rivero F; Cuesta J; Bastante T; García-Guimaraes M; Alfonso F
    Coron Artery Dis; 2017 Sep; 28(6):507-517. PubMed ID: 28562383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents.
    Ali ZA; Roleder T; Narula J; Mohanty BD; Baber U; Kovacic JC; Mintz GS; Otsuka F; Pan S; Virmani R; Sharma SK; Moreno P; Kini AS
    Circ Cardiovasc Interv; 2013 Oct; 6(5):507-17. PubMed ID: 24065447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.